Virtu Financial LLC G1 Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.2 - $4.98 $163,578 - $370,282	74,354 New	74,354 $170,000
Q4 2023 Feb 26, 2024	BUY	$1.12 - $3.73 $50,093 - $166,827	44,726 New	44,726 $136,000
Q3 2022 Nov 07, 2022	BUY	$5.17 - $16.99 $128,433 - $422,065	24,842 Added 246.42%	34,923 $436,000
Q2 2022 Aug 09, 2022	BUY	$4.04 - $8.51 $9,219 - $19,419	2,282 Added 29.26%	10,081 $50,000
Q1 2018 May 14, 2018	BUY	$19.05 - $41.76 $148,570 - $325,686	7,799 New	7,799 $289,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.